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Abstract Vesico-ureteral reflux (VUR) is a major contrib-
uting factor to end-stage renal disease in paediatric patients.
Primary VUR is a familial disorder, but little is known
about its genetic causes. To investigate the involvement of
12 functional candidate genes and two reported loci in
VUR, we performed a linkage study in four large, Dutch,
multi-generational families with multiple affected individ-
uals. We were unable to detect linkage to any of the genes
and loci and could exclude the GDNF, RET, SLIT2, SPRY1,
PAX2, AGTR2, UPK1A and UPK3A genes and the 1p13
and 20p13 loci from linkage to VUR. Our results provide





Vesico-ureteral reflux [VUR (MIM 193000)], the retrograde
passage of urine from the bladder, is one of the most
commonly detected congenital anomalies. With a preva-
lence of approximately 1% [1], VUR can be primary, due to
an incompetent valve mechanism at the uretero-vesical
junction, or secondary, due to a functional or anatomical
urethral obstruction. VUR is often accompanied by non-
neuropathic bladder/sphincter dysfunction (NNBSD). This
complex is a major cause of urinary tract infections in
children [2] and the sometimes resulting reflux nephropathy
is the cause of approximately 7% of end-stage renal disease
in paediatric patients in the Netherlands [3]. Severe primary
VUR can concur with congenital renal insufficiency based
on hypoplasia/dysplasia of one or both kidneys. Genetic
factors play an important role in the aetiology of primary
VUR, since siblings of affected children have a 32% risk of
VUR [4], and since there is 80% concordance between
monozygotic twins [5]. VUR may occur in isolation or as
part of a syndrome, such as renal-coloboma syndrome.
Apart from the recently published involvement of ROBO2
[6] little is known about the genetic causes of isolated
primary VUR in humans. The aim of the present study was
to confirm linkage to published candidate loci and genes.
So far, only one genome-wide linkage study has been
reported, which showed significant linkage to a 17 cM
locus on chromosome 1p13 in five Caucasian families and
suggestive linkage to chromosome 20p13 [7]. To date,
these results have not been replicated [8]. Embryonal
ectopic ureteral budding has been proposed to be a
mechanism for the development of VUR [9, 10]. Defects
of the RET and GDNF genes have been shown to cause
ectopic ureteral budding [11, 12]. Hence, these and other
genes involved in the RET/GDNF pathway are obvious
Pediatr Nephrol (2007) 22:1129–1133
DOI 10.1007/s00467-007-0492-4
Electronic supplementary material The online version of this article
(doi:10.1007/s00467-007-0492-4) contains supplementary material,
which is available to authorized users.
A. M. van Eerde (*):B. P. C. Koeleman:C. Wijmenga:
J. C. Giltay
Department of Medical Genetics KC.04.084.2,
University Medical Centre Utrecht,
P.O. Box 85090, 3508 AB Utrecht, The Netherlands
e-mail: a.vaneerde@umcutrecht.nl
T. P. V. M. de Jong
Department of Pediatric Urology,
University Medical Centre Utrecht,
Utrecht, The Netherlands
J. M. van de Kamp
Department of Clinical Genetics, VU Medical Centre,
Amsterdam, The Netherlandsfunctional candidate genes for VUR. Genes involved in
syndromal VUR and genes derived from mouse models
with urinary tract abnormalities (such as AGTR2) are also
attractive functional candidate genes for VUR. The aim of
this study was to assess the 1p13 and 20p13 loci and
appropriate candidate genes (Table 1) for their role in the
Dutch VUR population by performing linkage analysis in
four large families.
Methods
DNA of four unrelated Dutch VUR families was collected
(Fig. 1), which had been ascertained as part of a previous
study [19]. Of a total of 51 samples there were 21 affected
individuals. The families provided moderate power to detect
linkage as calculated with SLINK (probability of obtaining
LOD scores of at least 1.0, 2.0, or 3.0 was 74%, 49% and
18%, respectively). An affected phenotype for index patients
was based on their having been treated for primary VUR,
while for family members it was based on having a positive
case history (of actual VUR, or multiple urinary tract
infections with high fever as a child, or evidence of reflux
nephropathy, such as requiring renal replacement therapy
without obvious other causes) (see also Fig. 1). All other
family members were classified as “unknown”, despite
negative imaging results at a young age in some of them.
Dutch paediatric urologists consider the use of voiding
cysto-urethrography (VCUG) in asymptomatic children just
for research purposes inappropriate. Therefore, we could not
classify family members as “not affected”.
Some of the candidate genes play roles in congenital
anomalies of the kidney and urinary tract (CAKUT)
phenotypes (such as VUR, duplex collecting system and
renal hypoplasia in mice) [9, 15]. Therefore, families in
which one or more patients had these kinds of phenotypes
(and VUR) were not excluded. All participants gave their
informed consent, and the Medical Ethics Committee of the
University Medical Centre Utrecht approved the study.
For the 1p13 locus, we started out with the markers
flanking the reported 1p13 linkage peak (D1S1653 and
GATA176C01) [7]. Both markers now have different map
locations if one is reviewing the most recent updates of the
Ensembl (v38) and Marshfield databases. In fact, the
telomeric marker GATA176C01 (D2S2972) even maps to
a different chromosome (2q11). The centromeric marker
D1S1653, which in our query result has roughly the same
genetic position (164.09-166 cM) as previously published
[7, 8], localizes on chromosome 1q23. Therefore, we tested
both the entire 1p13–1q23 and 2q11 loci for linkage to
VUR. A total of 11 short tandem repeat polymorphism
(STRP) markers for 1p13–1q23 and seven STRP markers
for 2q11 (with an average intermarker distance of 5 cM)
were chosen to saturate the regions spanning 55.3 Mb on
chromosome 1 and 46.3 Mb on chromosome 2. For 20p13,
five STRP markers were selected, spanning 12.0 Mb
(Supplementary Table 1 Online).
For the candidate genes, we aimed to cover the specific
location with an average intermarker distance of 2 cM
(Supplementary Table 1 Online).
Markers were genotyped as described elsewhere [20]i n
the 51 family members, together with three Centre d’Etude
aTwo-point analysis of marker D22S928; 0.5 cM away from UPK3A.
bAlpha: estimated proportion of families linked to result in corresponding heterogeneity LOD (HLOD). HLOD analyses were performed, but did
not contribute and are not discussed.
Table 1 Genes tested in linkage study of four large multi-generational
VUR families (LOD logarithm of the odds, NPL non-parametric
linkage, HLOD heterogeneity LOD, A ureteral budding, B RET/GDNF
pathway, C mouse and human phenotype, D linkage study, E in
urothelial plaque with UPK3A (mouse model), F mouse model)
Gene Relevance Chromosome Location (cM) Multi-point LOD score






GDNF A/B 5 54 −2.03 0.70 0.22 0.10 0.01 [13]
RET A/B 10 66 −2.55 −0.85 0.80 0.00 0.00 [13]
SLIT2 A/B 4 34 −2.15 0.35 0.32 0.15 0.80 [14]
SPRY1 A/B 4 126 −3.25 −0.98 0.86 0.00 0.00 [14]
PAX2 A/B 10 124 −3.43 −0.49 0.63 0.00 0.00 [13]
AGTR2 A/C X 71 −3.81 −1.18 0.88 0.00 0.00 [15]
HLADRB1 D6 4 6 −1.84 0.25 0.35 0.20 0.16 [16]
UPK1A E1 9 6 1 −2.90 −0.62 0.69 0.00 0.00 [17, 18]
UPK1B E 3 138 0.15 1.24 0.12 0.65 0.43 [17, 18]
UPK2 E1 1 1 1 5 −1.50 −0.22 0.52 0.00 0.00 [17, 18]
UPK3A A/F 22 53 −3.40
a −1.20 0.80 0.00 0.00 [17, 18]
UPK3B E7 8 9 −1.08 0.59 0.25 0.00 0.00 [17, 18]
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three negative controls. The polymerase chain reactions
(PCRs) were carried out on a GeneAmp PCR system 9700
machine (Applied Biosystems). The PCR products were
s e p a r a t e do na nA B I3 7 3 0D N As e q u e n c e r( A p p l i e d
Biosystems). The output was analysed with Genemapper 3.5
software (Applied Biosystems). Two investigators checked
all the genotypes, and we verified the identity of the
markers by comparing genotypes of the CEPH reference
samples with the CEPH genotype database. A Mendelian
inheritance check was performed with PedCheck 1.1
software [21], and samples with Mendelian errors were
excluded from the linkage analysis.
Multi-point (both parametric and non-parametric) anal-
yses were performed for all markers with GENEHUNTER
(version 2.1_r2 beta), or GENEHUNTER PLUS (for X-
linked dominant calculations in AGTR2)[ 22]. We assumed
an autosomal dominant model with reduced penetrance
(0.8) for the parametric analyses, similar to the parameters
previously described [7, 23]. This mode of inheritance
agreed most with our pedigrees (Fig. 1). The phenocopy
rate was equal to the population frequency of VUR (0.01).
Disease allele frequency was assumed to be 0.01. Regions
with a parametric LOD score ≤− 2 were defined as
exclusion regions [24]. All significance levels applied in
this study were based on previously proposed thresholds
[24, 25].
Results
Twelve functional candidate genes were screened for
linkage to VUR. The multi-point LOD score obtained for
each of the 12 genes (at the genetic location of the gene) is
shown in Table 1, together with the non-parametric linkage
(NPL) score and corresponding P value. Multi-point LOD
scores with NPL score and corresponding P value for all
markers are shown in Supplementary Table 1 Online. Eight
of the functional candidate genes (GDNF, RET, SLIT2,
SPRY1, PAX2, AGTR2, UPK1A and UPK3A) were com-
pletely excluded. For the other four, the results were
inconclusive, although linkage is highly unlikely.
Forthereportedlinkageregions,nosignificantlinkagewas
detected either. One of the markers reported to be on
chromosome 1 [7] appeared to reside on chromosome 2
(see Methods section). Therefore, both the original locus on
chromosome 1p13 and the “new” locus on chromosome 2q11
were tested. The chromosome 1 locus was completely
excluded, as the multi-point LOD score was below −2f o r
the entire region. Sixty-one percent of the locus on chromo-
some 2 could be totally excluded. The locus on
chromosome 20p13 was completely excluded (Fig. 2).
Discussion
We performed a comprehensive screen of 12 functional
candidate genes and two reported loci (which later proved to
be three separate regions). All the genes, except HLADRB1,
had, in some way, been proven to play a role (indirectly) in
ectopic ureteral budding and were thought likely to play a
role in human primary VUR. However, we did not detect
linkage to any of them. We were able to exclude eight
genes (GDNF, RET, SLIT2, SPRY1, PAX2, AGTR2, UPK1A
and UPK3A) as major players in these Dutch VUR families.
ROBO2, the receptor of SLIT2 [26], had already been ruled
out, since it had been sequenced in the four probands in a
parallel study; no mutations were detected [6], therefore it
was not included in the present study. Nevertheless, these
Fig. 1 VUR family pedigrees (21 affected individuals in 51
samples). Family 1: 2 left kidney had to be removed at 5 years; 3,
4 end-stage renal disease (ESRD); 9 VUR and ESRD; 15 VUR and
duplex collecting system; 19 VUR; 18 VUR and nephropathy.
Family 2: 68, 69, 73 not included in analyses; 25, 26, 30 and 31
VUR; 33 VUR and dysfunctional voiding. Family 3: 39, 42, 43 VUR
and dysfunctional voiding symptomatology; 47 VUR, dysfunctional
voiding, meatal stenosis. Family 4: 50 and 52 recurrent urinary tract
infections (UTIs) as a child, duplex collecting system; 55 UTIs and
urinary tract operation; 49 VUR; 51 VUR and dysfunctional voiding
symptomatology
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The moderate power these pedigrees provided to reveal
linkage means that it is possible that the genes that showed
inconclusive results might have yielded positive results in a
more highly powered study. Since the RET/GDNF pathway
plays such a central role in ureteral budding, it is plausible
that these genes are, indeed, causative factors for VUR but
that the pathogenetic variants lie in upstream or down-
stream regulatory elements. Other genes that are more or
less directly involved in the RET/GDNF pathway or in
ureteral budding in general, such as EYA1, GATA3, WT1 or
BMP4 [27], may also contribute to VUR.
We could not confirm linkage for any of the reported
loci, and we were even able to exclude completely the 1p13
and 20p13 loci. This is the second non-replication of the
1p13 region [8]. Our data show that the 1p13 locus resides
either on chromosome 1p13 to 1q23 or on 2q11. We also
excluded linkage to most of this 2q11 locus.
We realize that these families show some intra-familial and
inter-familial heterogeneity. This heterogeneity, however, is
similar to that described in VUR families by others [7]. In
older generations (Fig. 1)i ti si m p o s s i b l et oh a v em o r ed a t a
than self-reported history, but the described phenotypes are
very likely to be caused by VUR. Therefore, we did assign
the affected status to these patients, but we are aware of the
fact that this is one of the limitations of the study.
One of the major obstacles for linkage studies in VUR is
the relative rarity of large pedigrees, which is due to many
children growing out of the disorder, the reduced penetrance
of the trait, and the locus heterogeneity [8]. Furthermore,
when doing linkage studies in relatively few families, one
assumes a large effect of one or few genes. Maybe the genes
of interest do play a role, but their effect is too small to be
picked up. Therefore, studies like ours and those published
[7, 8] are useful to search for one or more major genes. For
this reason, association studies with large sample sizes may
offer a better approach for unravelling the genetics of VUR.
Both a hypothesis-free (genome-wide) approach and a more
elaborate candidate gene study would be interesting follow-
up studies. Alternatively, it might be interesting to study the
role of copy number variants (CNVs) in VUR, since,
recently, such CNVs were proposed to be involved in the
mechanism underlying a number of complex disorders [28,
29]. Apart from those in a recent study by Lu et al. [6], no
genes have been published that appear to be directly
involved in primary VUR in humans, and no replication of
the linkage peak on 1p13 [7] has been reported. Our results
provide further evidence for genetic heterogeneity in VUR.
We hypothesize that several genes, which still have to be
identified but which are likely to affect ureteral budding, will
each play a role in the pathogenesis of VUR.
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